Reduced Cervical Cancer Screening for HPV-Vaccinated Women
-
By
February 3, 2026
-
5 min
A modeling study conducted by Kine Pedersen, PhD, from the University of Oslo, reveals that cervical cancer screening intensity in women can be significantly reduced if they have received the HPV vaccine. Variations in optimal screening strategies depend on the age at vaccination and the type of vaccine used. Women vaccinated between ages 12 and 24 may only need 2 to 3 screenings throughout their lives, as opposed to the current guideline of every 5 years from ages 25 to 69. These strategies show cost-effectiveness and favorable harm-benefit ratios and could lead to fewer colposcopy referrals while effectively preventing cervical cancer.
1. Screening intensity can be reduced for HPV vaccinated women. 2. Optimal strategies depend on vaccination age and vaccine type. 3. Women vaccinated at 12-24 need 2-3 screenings in their lifetime. 4. Strategies maintained cost-effectiveness and favorable harm-benefit ratios. 5. Implementation requires reliable vaccination data and organized screening infrastructure. 6. Current guidelines recommend every 5 years for unvaccinated women.
Listen Tab content
